Navigation Links
Analyzing The Side Effects Of Sirolimus Stents

Based on findings of a recent study researchers from Sweden say they have found that implantation //of a sirolimus-eluting stent is associated with coronary vasoconstriction in areas adjacent to the treated vessel that is not seen with bare metal stents.

Sirolimus-eluting stents are widely used for percutaneous coronary interventions because of their excellent long-term clinical and angiographic outcome, however, recent concerns have been raised that the stents could lead to increased rates of stent thrombosis due to delayed or absent endothelialization.

Researchers compared endothelial function and coronary vasomotor response to exercise in 14 patients fitted with sirolimus-eluting stents and 11 control patients receiving bare metal stents. It was observed that after 6 months, the reference vessel showed an increase in exercise-induced vasodilation in both groups, with a mean increase in diameter of 13%, and no vasomotion in the stented vessel segments. In adjacent segments that were proximal and distal to the bare metal stent there were also increases in exercise-induced vasodilation of 15% and 17%, respectively. In contrast, exercise-induced vasoconstriction - indicating endothelial dysfunction - occurred with the sirolimus-eluting stent at these locations, with decreases in vessel diameter of 12% and 15%, respectively (p<0.001 vs controls). Vasodilatory capacity was preserved, with sublingual nitroglycerin associated with maximal vasodilation of these vessel segments in both groups.

Researchers are of the opinion that Paradoxic vasoconstriction in a vessel segment not subjected to percutaneous transluminal coronary angioplasty barotrauma may be due to diffusion of the antiproliferative drug from the stent to the peri-stent region, inducing endothelial dysfunction. However some are of the opinion that inadequate endothelial coverage could lead to insufficient nitric oxide to promote normal vasodilation with exercise. In concl usion researchers say that they will not be able to come to any positive finding, until further studies are done in this field.

For more information read:
http://www.medindia.net/
interactives/angioplasty.asp

'"/>




Related medicine news :

1. Analyzing The Side Effects Of Some Common Medications
2. Analyzing The Risk Factors For Diabetic Neuropathy
3. Analyzing Client-Centered Therapy.
4. Acupuncture May Help Chemotherapy Side Effects
5. Chemotherapy Pill Has Fewer Side Effects Than IV
6. Therapy Boosts Chemotherapy Effects
7. Smoking and its Effects
8. Reducing The After Effects of Tonsillectomy
9. The Side Effects Of Estrogen Therapy
10. The Harmful Effects Of Cigarette Smoke
11. Lung Therapy Found To Have Long-Term Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic ... Frederick area economy by obtaining investment capital for emerging technology companies. SCP ... that have already resulted in more than a million dollars of capital investment ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider ... and other difficult to transfect cells, announces its launch of the PluriQ™ G9™ ... Editing System is a complete system for culturing and transfecting human pluripotent ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology: